These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26238454)

  • 1. Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study.
    Lin J; Khetarpal SA; Terembula K; Reilly MP; Wilson FP
    BMC Nephrol; 2015 Aug; 16():130. PubMed ID: 26238454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria.
    Lin J; Reilly MP; Terembula K; Wilson FP
    PLoS One; 2014; 9(12):e114397. PubMed ID: 25490096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus.
    Yun JS; Ahn YB; Song KH; Yoo KD; Park YM; Kim HW; Ko SH
    Diabet Med; 2016 May; 33(5):639-43. PubMed ID: 26202453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Winfield K; Stoll T; Bringans SD; Lipscombe RJ; Davis TME
    Diabetes Care; 2017 Nov; 40(11):1548-1555. PubMed ID: 28851702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.
    Ballantyne CM; Bays HE; Braeckman RA; Philip S; Stirtan WG; Doyle RT; Soni PN; Juliano RA
    J Clin Lipidol; 2016; 10(3):635-645.e1. PubMed ID: 27206952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Miner Electrolyte Metab; 1999; 25(4-6):258-62. PubMed ID: 10681649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
    Borén J; Watts GF; Adiels M; Söderlund S; Chan DC; Hakkarainen A; Lundbom N; Matikainen N; Kahri J; Vergès B; Barrett PH; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2218-24. PubMed ID: 26315407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
    Pek SLT; Sum CF; Yeoh LY; Lee SBM; Tang WE; Lim SC; Tavintharan S
    Metabolism; 2017 Jul; 72():75-82. PubMed ID: 28641786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired postprandial lipemic response in chronic kidney disease.
    Saland JM; Satlin LM; Zalsos-Johnson J; Cremers S; Ginsberg HN
    Kidney Int; 2016 Jul; 90(1):172-80. PubMed ID: 27162092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid levels and decreased estimated glomerular filtration rate in patients with type 2 diabetes: A cohort study and meta-analysis.
    Wang J; Yu Y; Li X; Li D; Xu C; Yuan J; Wei S; Li X; Yang K; Zheng D; Tang Y; Yang H; Wu T; He M
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3046. PubMed ID: 30003679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.
    Aroner SA; Yang M; Li J; Furtado JD; Sacks FM; Tjønneland A; Overvad K; Cai T; Jensen MK
    Am J Epidemiol; 2017 Sep; 186(6):736-744. PubMed ID: 28520887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
    Martinelli N; Baroni M; Castagna A; Lunghi B; Stefanoni F; Tosi F; Croce J; Udali S; Woodhams B; Girelli D; Bernardi F; Olivieri O
    Thromb Haemost; 2019 Feb; 119(2):192-202. PubMed ID: 30602199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.